A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693.

Inclusion Criteria: For Hepatic: * Participant with a diagnosis of chronic and stable hepatic impairment For Healthy: * Participant with no clinically significant medical history, physical examination, laboratory profiles, vital signs, or 12-lead ECGs, All participants: \- Body weight ≥ 50 kg; BMI within the range of 18.0 to 40.0 kg/m2 (inclusive) as measured at screening Exclusion Criteria: * Participant with impaired hepatic function has eGFR \< 60 mL/minute/1.73 m2 and participant with normal hepatic function has eGFR \< 90 mL/minute/1.73 m2 * Positive test for HIV at screening * History or presence of clinically significant thyroid disease * History or presence of clinically significant or unstable medical or psychiatric condition * History of any major surgical procedure within 30 days prior to study intervention